Harvard spin-off CELLVIE raises $5.5M of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation as a new treatment modality
/PRNewswire/ -- cellvie Inc., a leader in Therapeutic Mitochondria Transplantation (TMT), an approach developed at Harvard, closes a $5.5 Million financing to...
United States James Mccully Alexander Schueller Sakae Asanuma Frank Schueler Kizoo Technology Capital
Source: prnewswire.com